NIH Research Matters

Middle-aged woman holds the back of her left hand to her forehead.
News

Antiviral drug did not improve Long COVID symptoms

A clinical trial for Long COVID found that treating patients with a common antiviral drug for up to 25 days did not improve symptoms.
X-ray of the human lung.
News

tRNA treatment may help restore cystic fibrosis proteins

Lipid nanoparticles delivering engineered transfer RNA restored functional proteins in cell and animal models of cystic fibrosis.
Medical illustration of Clostridioides difficile bacteria
News

Bacterial infection may alter developing gut

C. difficile bacteria caused lasting changes to cells in the intestines of newborn mice.

 

Displaying 64 - 70 of 912

Source of gastrointestinal problems in myotonic dystrophy

Mouse studies reveal why some people with muscular dystrophy often have gastrointestinal problems.

Protective vitamin shots for newborns on decline

Scientists identified an ongoing drop in newborns receiving a vitamin shot that helps to prevent dangerous bleeding.

One dose of HPV vaccine as effective as two

A single dose of the human papillomavirus vaccine is as effective as two doses.

2025 NIH Research Highlights - Basic research insights

Noteworthy NIH advances in basic research include insights into the effects of repeated head trauma in young athletes, how cancer cells cooperate, and progress toward a broad-spectrum antiviral.

2025 NIH Research Highlights - Human health advances

NIH accomplishments in disease prevention, diagnosis, and treatment include progress in brain-computer interfaces, treatments for rare diseases in children, and cervical cancer advances.

2025 NIH Research Highlights - Promising medical findings

NIH findings with potential for enhancing human health include new insights into Alzheimer’s disease dementia, making CAR T-cells within a living body, and a non-opioid compound for chronic pain relief.

A key to long-term HIV control

NIH-funded clinical studies suggest that boosting a certain type of immune cell may help control HIV without the need for life-long treatment.